BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37066775)

  • 1. The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute Liver Failure.
    Zhang L; Ma T; Yan Y; Chen YY; Zhu XH; Ren HZ
    Comb Chem High Throughput Screen; 2023; 26(15):2738-2748. PubMed ID: 37066775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies.
    Yuan M; Yao L; Hu X; Jiang Y; Li L
    Front Genet; 2022; 13():1004912. PubMed ID: 36246593
    [No Abstract]   [Full Text] [Related]  

  • 3. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
    Guo ZY; Zhu ZT
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang X; Wang H; Han Y; Zhu M; Song Z; Zhan D; Jia J
    Onco Targets Ther; 2020; 13():11315-11326. PubMed ID: 33177839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
    Liu K; Li Y; Yu B; Wang F; Mi T; Zhao Y
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling.
    Gong C; Ai J; Fan Y; Gao J; Liu W; Feng Q; Liao W; Wu L
    Onco Targets Ther; 2019; 12():8537-8552. PubMed ID: 31802891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
    Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L
    J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
    Wang Y; Gao B; Tan PY; Handoko YA; Sekar K; Deivasigamani A; Seshachalam VP; OuYang HY; Shi M; Xie C; Goh BKP; Ooi LL; Man Hui K
    FASEB J; 2019 Aug; 33(8):8759-8770. PubMed ID: 31022357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
    Zhang R; Ai J; Wang J; Sun C; Lu H; He A; Li M; Liao Y; Lei J; Zhou F; Wu L; Liao W
    J Transl Med; 2022 Jul; 20(1):325. PubMed ID: 35864529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma.
    Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y
    Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
    Zhang Q; Su R; Shan C; Gao C; Wu P
    Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure.
    Wang Y; Wang JL; Ma HC; Tang ZT; Ding HR; Shi XL
    Biochem Biophys Res Commun; 2019 Jan; 508(3):682-689. PubMed ID: 30528392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory role of microRNA-mRNA co-expression in hepatitis B virus-associated acute liver failure.
    Pan K; Wang Y; Pan P; Xu G; Mo L; Cao L; Wu C; Shen X
    Ann Hepatol; 2019; 18(6):883-892. PubMed ID: 31521462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NCAPG in various of tumors.
    Cai X; Gao J; Shi C; Guo WZ; Guo D; Zhang S
    Biomed Pharmacother; 2022 Nov; 155():113635. PubMed ID: 36095957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
    Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J
    Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Yang H; Pu L; Li R; Zhu R
    J Gastrointest Oncol; 2023 Apr; 14(2):900-912. PubMed ID: 37201048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure.
    Shi M; Zhou Z; Zhou Z; Shen L; Shen J; Zhou G; Zhu R
    Ann Transl Med; 2022 Jul; 10(14):775. PubMed ID: 35965803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis.
    Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY
    Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of microRNA-124 prevents the development of acute liver failure through the upregulation of PIM-3.
    Zan T; Piao L; Yang X; Gu Y; Liu B
    Exp Physiol; 2020 Jan; 105(1):108-119. PubMed ID: 31628693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.